Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of CAIV-T vs FluMist in Healthy Participants
NCT00192335Phase 3Completed
- Sponsor
- MedImmune
- Start
- Jul 2004
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of live attenuated influenza vaccine in influenza (2 arms), sponsored by MedImmune. Primary endpoint: Strain-specific geometric mean titers for serum hemagglutination inhibition. Started Jul 2004; status: completed.
02
Drugs
live attenuated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00192335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00192335.